Workflow
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025
Globenewswire· 2025-11-24 14:00
--Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development-- SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc., (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics, today announced new data describing a scalable framework for loading therapeutic small interfering RNAs (siRNA) and phosphorodiamidate morpholino oligomers (PMO) into ...
Schouw & Co. share buy-back programme, week 47 2025
Globenewswire· 2025-11-24 14:00
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Tr ...
Regarding the Acquisition of Own Shares
Globenewswire· 2025-11-24 14:00
The Board of ŽEMAITIJOS PIENAS, AB (hereinafter – the Company), taking into account that a reserve for the acquisition of own shares has been formed and acting in accordance with the decision of the Annual General Meeting of Shareholders of ŽEMAITIJOS PIENAS, AB held on 29 April 2025, has resolved to carry out the acquisition of the Company’s ordinary registered shares with a nominal value of EUR 0.29 through Nasdaq CSD SE. Terms of the Share Buyback: Start date of the acquisition: 26 November 2025End date ...
Kyivstar Launches Starlink Direct to Cell Satellite Connectivity in Ukraine
Globenewswire· 2025-11-24 14:00
Today’s Launch Makes Ukraine the First Country in Europe Where Starlink Direct to Cell is Available to Customers Dubai and Kyiv, November 24, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that Kyivstar Group Ltd. (“Kyivstar”) (Nasdaq: KYIV; KYIVW), VEON’s digital operator in Ukraine, has launched Starlink’s Direct to Cell satellite technology for its customers in Ukraine. Powered by Starlink’s Direct to Cell constellation, the service will enable all Ukrainians to stay ...
Report on the unaudited financial performance of the bank during the nine month of 2025
Globenewswire· 2025-11-24 14:00
Urbo bankas UAB (hereinafter - “the Bank”), company code 112027077, address: Konstitucijos pr.18B, Vilnius. In the first three quarters of this year, Lithuania-based Urbo Bankas recorded double-digit growth in both its loan and deposit portfolios. Year-to-date, the bank’s loans have grown by more than 26% (from EUR 414.5 million) and deposits by 22% (from EUR 557.3 million). “This year, we have continued our consistent growth in both deposit and loan categories. In order to strengthen the bank’s capital ba ...
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Globenewswire· 2025-11-24 14:00
HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced it has entered into definitive agreements for the issuance and sale of an aggregate of 4,477,614 shares of its common stock at an offering price of $0.335 per shar ...
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
Globenewswire· 2025-11-24 14:00
Taipei, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the Company has reached a set of regulatory and clinical milestones that together mark its first commercial entry into U.S. eye care and limbal stem cells (“LSC”) exosome‑based therapeutics. Through its partner 3D Global Biotech Inc. (“3D Global Biotech”), Exovisse ...
Baltic Horizon Fund portfolio valuations: preliminary results
Globenewswire· 2025-11-24 14:00
Baltic Horizon Fund (the Fund) has received preliminary results of portfolio valuations by the independent real estate appraisers. Based on the preliminary assessment, the fair value of the Baltic Horizon Fund portfolio is EUR 208.7 million (reported on the interim financial statements as of 30 September 2025: EUR 228.3 million). The fund manager will finalise the review of valuation models and report the final effect of these, together with the release of NAV of the Fund for the end of November 2025. The s ...
Digerati Technologies Expands International Reach with Acquisition of Ricochet Global
Globenewswire· 2025-11-24 14:00
Port Jefferson, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Digerati Technologies, Inc., (“Digerati,” the “Company,” “we,” “our” or “us”) (OTCID: DTGI) is pleased to announce it has successfully closed on its acquisition of Ricochet Global (“Ricochet”), a provider of facilities and cloud-based services to telecommunications operators worldwide, with specific focus on Africa, Middle East and Persian Gulf. Ricochet employs the latest in switching and routing architecture allowing for exceptional quality while maint ...
Frequency Electronics, Inc. Announces Contract Increase for Approximately $5 Million
Globenewswire· 2025-11-24 14:00
GARDEN GROVE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- FEI-Zyfer, Inc., a wholly-owned subsidiary of Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, is pleased to announce the receipt of two follow-on change orders with a combined value of approximately $4.75M for on-going work on the development and manufacture of a customized version of our high-precision airborne time, synchronization, and frequency distribution s ...